Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/27/2003WO2003005033A8 Carcinoma-related peptides
03/27/2003WO2003004643A3 Reversed mammalian protein-protein interaction trap
03/27/2003WO2003000843A3 P53 binding protein-related protein in cardiomyopathy
03/27/2003WO2003000732A3 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications
03/27/2003WO2002100876B1 Dock 3 tumor suppressor gene
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002092837A9 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
03/27/2003WO2002083888A3 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
03/27/2003WO2002079403A9 Method for modifying plant biomass
03/27/2003WO2002079227A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002077193A8 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
03/27/2003WO2002077168A3 Mch1r deficient mice
03/27/2003WO2002074237A3 Compositions and methods for the therapy and diagnosis of kidney cancer
03/27/2003WO2002072785A3 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
03/27/2003WO2002070691A3 Abcg4 transporter and uses thereof
03/27/2003WO2002068633A3 Compositions and methods relating to lung specific genes and proteins
03/27/2003WO2002068587A3 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3
03/27/2003WO2002064799A3 Optimized messenger rna
03/27/2003WO2002064733A3 Protein-protein interactions
03/27/2003WO2002060918A3 Haplotypes of the tnf gene
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002058534A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/27/2003WO2002056829A3 Methods for preparing purified daptomycin
03/27/2003WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
03/27/2003WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes
03/27/2003WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response
03/27/2003WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae)
03/27/2003WO2002050271A3 Human ion channel protein and polynucleotides encoding the same
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002046414A3 Human g-protein coupled receptor expressed highly in kidney
03/27/2003WO2002046403A3 Regulation of human patched-like protein
03/27/2003WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002040506A3 Modified clostridial neurotoxins with altered biological persistence
03/27/2003WO2002036633A3 Human 7tm proteins and polynucleotides encoding the same
03/27/2003WO2002034782A8 Endozepine-like polypeptide nov1 and nucleic acid encoding the same
03/27/2003WO2002034205B1 Using heat shock proteins to increase immune response
03/27/2003WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002033084A3 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
03/27/2003WO2002031512A3 Molecular interactions in hematopoietic cells
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026985A3 G-protein coupled recptors
03/27/2003WO2002026774A3 Melanocortin receptor ligands
03/27/2003WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/27/2003WO2002024741A3 Isolated genomic polynucleotide fragments from chromosome 7
03/27/2003WO2002024640A3 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
03/27/2003WO2002022817A3 Nuclear receptor l66 and methods of use
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002020050A9 Eiav p26 deletion vaccine and diagnostic
03/27/2003WO2002018954A9 Inhibition of cmv infection and dissemination
03/27/2003WO2002018573A3 54370, a novel human sulfate transporter and uses therefor
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002014491A3 A hematopoietic growth factor-like protein obtained from a cdnalibrary from hs-5 stromal cell line
03/27/2003WO2002012902A3 Split-ubiquitin based reporter systems and methods of their use
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002009750A3 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
03/27/2003WO2002008411A3 Methods of creating dwarf phenotypes in plants
03/27/2003WO2002008259A3 Human cytokine receptor
03/27/2003WO2002006329A3 Human polynucleotides and polypeptides encoded thereby
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001098520A8 Transgenically produced platelet derived growth factor
03/27/2003WO2001083794A3 Dna transfection system for the generation of infectious influenza virus
03/27/2003WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer
03/27/2003WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
03/27/2003WO2001061346A3 Methods for identifying agents causing a lethal phenotype
03/27/2003US20030061637 Polynucleotides for root trait alteration
03/27/2003US20030061635 Nucleotide sequences coding protein for use in controlling physiological responses in plants
03/27/2003US20030061634 Sucrose-binding proteins
03/27/2003US20030061632 Polynucleotides useful for modulating transcription
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060618 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of lyme disease
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060615 Novel Bak binding protein, DNA encoding the protein, and methods of use thereof
03/27/2003US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/27/2003US20030060613 Protein for use in the treatment of bone, tumor and inflammatory disorders
03/27/2003US20030060606 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
03/27/2003US20030060605 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases
03/27/2003US20030060604 Apolipoprotein agonist for use in the treatment of dyslipidemia
03/27/2003US20030060602 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060601 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060600 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060512 Modulation of inflammation related to columnar epithelia
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060444 In which an effector cell is transformed with DNA coding for chimeric receptor containing two or more cytoplasmic signalling components derived from tetraspan-transmembrane protein or antigens; anticancer agents
03/27/2003US20030060435 Method of cancer treatment by p53 protein control
03/27/2003US20030060434 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060432 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/27/2003US20030060416 Blk genes, gene products and uses thereof in apoptosis
03/27/2003US20030060413 Derivatives of pseudo-peptides, their preparation and their biological uses
03/27/2003US20030060412 Dissolving in aqueous base or in aqueous acid, neutralized to a pH at which substantially no amino acid racemization; stimulate insulin secretion for the treatment of diabetes, obesity
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060409 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY25, expressed highly in immune-related tissues
03/27/2003US20030060408 Metal-binding compounds and uses therefor
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030060403 Hepatocyte growth factor manufactured by gene recombination; treatment of dementia, senile dementia of Alzheimer type, cerebral stroke, and cerebral infarction
1 ... 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 ... 2916